Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review

Pathol Res Pract. 2019 Jun;215(6):152413. doi: 10.1016/j.prp.2019.04.005. Epub 2019 Apr 6.

Abstract

Cytokeratin 20 (CK20) is one of the most common immunohistochemical markers in the routine practice of a pathology lab, as biopsies from the urinary tract encompass a wide spectrum of lesions which may pose issues in their detection and classification. In this review, we aim to outline the diagnostic accuracy and prognostic value of CK20 in flat urothelial lesions, papillary non-invasive and invasive urothelial carcinoma, molecular subgroups and variant histology, and we briefly discuss its limitations and potential pitfalls.

Keywords: Cytokeratin 20; Molecular subtyping; Thelial carcinoma; Uro; Urothelial lesions; Variant histology.

Publication types

  • Systematic Review

MeSH terms

  • Biomarkers, Tumor / analysis
  • Carcinoma, Papillary / diagnosis
  • Carcinoma, Papillary / pathology
  • Carcinoma, Transitional Cell / diagnosis
  • Carcinoma, Transitional Cell / pathology
  • Humans
  • Keratin-20 / analysis
  • Keratin-20 / biosynthesis
  • Prognosis
  • Urinary Bladder Neoplasms / diagnosis
  • Urinary Bladder Neoplasms / pathology
  • Urologic Neoplasms / diagnosis
  • Urologic Neoplasms / pathology*
  • Urothelium / pathology*

Substances

  • Biomarkers, Tumor
  • KRT20 protein, human
  • Keratin-20